| Jennifer Papp, LMSW | |
|
3 Family Practice Dr, Kingston, NY 12401-6449 | |
| (845) 338-2562 | |
| Not Available |
| Full Name | Jennifer Papp |
|---|---|
| Gender | Female |
| Speciality | Social Worker |
| Location | 3 Family Practice Dr, Kingston, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114331592 | NPI | - | NPPES |
| 01420795 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Secondary |
| 104100000X | Social Worker | PO3863 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Papp, LMSW 3 Family Practice Dr, Kingston, NY 12401-6449 Ph: (845) 338-2562 | Jennifer Papp, LMSW 3 Family Practice Dr, Kingston, NY 12401-6449 Ph: (845) 338-2562 |
News Archive
iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced approval by the U.S. Food and Drug Administration for use of the company's next generation mammography computer-aided detection platform, PowerLook Advanced Mammography Platform, with Digital CAD for Philips' MicroDose Full-Field Digital Mammography System.
Central and Eastern Europe is facing 'significant challenges' in combating a multi-billion euro, and often lethal, trade in fake medicines, security and pharmaceutical groups have warned, Inter Press Service reports in an article that examines the scope of the problem in a region now identified as a key smuggling route in an illicit trade which is growing every year.
The U.S. Food and Drug Administration is alerting health care providers to no longer implant end-stage heart failure patients with Medtronic's Heartware Ventricular Assist Device (HVAD) System due to a growing body of observational clinical comparisons that demonstrates a higher frequency of neurological adverse events and mortality associated with the system when compared to other commercially available devices, as well as complaints that the internal pump may delay or fail to restart.
Cochlear Limited, the global leader in implantable hearing solutions, is proud to highlight the success of Cochlear Link, an innovative customer service offering that makes it easier for cochlear implant clinics to serve their patients while reducing costs.
Statins may be best known for their ability to reduce cholesterol, but a research report appearing in the May 2011 issue of the Journal of Leukocyte Biology shows that these same drugs could also play a crucial role in the reduction of lung damage resulting from severe abdominal sepsis and infection.
› Verified 5 days ago